(Q44025370)

29 November 2017

Polymer delivery of camptothecin against 9L gliosarcoma: release, distribution, and efficacy (English)

1 reference

29 November 2017

1 reference

4

Peter C Burger

1 reference

29 November 2017

6

Jon Weingart

1 reference

29 November 2017

5

Henry Brem

1 reference

29 November 2017

Phillip B Storm

1

1 reference

29 November 2017

John L Moriarity

series ordinal

2

1 reference

29 November 2017

Betty Tyler

series ordinal

3

1 reference

29 November 2017

1 February 2002

1 reference

Journal of Neuro-Oncology

29 November 2017

1 reference

29 November 2017

56

1 reference

29 November 2017

3

1 reference

29 November 2017

209-217

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1015003232713

29 November 2017

0 references

cites work

Studies on therapeutic effectiveness of drugs with tumor weight and survival time indices of Walker 256 carcinosarcoma

1 reference

12 December 2020

Interstitial delivery of carboplatin via biodegradable polymers is effective against experimental glioma in the rat.

1 reference

12 December 2020

Differential interactions of camptothecin lactone and carboxylate forms with human blood components.

1 reference

12 December 2020

A camptothecin-resistant DNA topoisomerase I mutant exhibits altered sensitivities to other DNA topoisomerase poisons

1 reference

12 December 2020

Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I

1 reference

12 December 2020

Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma.

1 reference

12 December 2020

Camptothecin effects on DNA synthesis in murine leukemia cells

1 reference

12 December 2020

DNA topoisomerase poisons as antitumor drugs

1 reference

12 December 2020

Effects of camptothecin on RNA synthesis in leukemia L1210 cells

1 reference

12 December 2020

Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study

1 reference

12 December 2020

Preliminary pharmacologic and clinical evaluation of camptothecin sodium (NSC-100880).

1 reference

12 December 2020

Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain.

1 reference

12 December 2020

On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex

1 reference

12 December 2020

DNA topoisomerase I--targeted chemotherapy of human colon cancer in xenografts

1 reference

12 December 2020

Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain

1 reference

12 December 2020

Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin

1 reference

12 December 2020

Local delivery of the topoisomerase I inhibitor camptothecin sodium prolongs survival in the rat intracranial 9L gliosarcoma model.

1 reference

12 December 2020

Bioerodible polyanhydrides as drug-carrier matrices. II. Biocompatibility and chemical reactivity

1 reference

12 December 2020

A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues

1 reference

12 December 2020

Semi‐quantitative Analysis of DNA Topoisomerase‐I mRNA Level Using Reverse Transcription‐Polymerase Chain Reaction in Cancer Cell Lines: Its Relation to Cytotoxicity against Camptothecin Derivative

1 reference

12 December 2020

The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers

1 reference

12 December 2020

Bioerodible polyanhydrides as drug-carrier matrices. I: Characterization, degradation, and release characteristics

1 reference

12 December 2020

Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors

1 reference

12 December 2020

Plant antitumor agents. 18. Synthesis and biological activity of camptothecin analogues

1 reference

12 December 2020

Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin

1 reference

12 December 2020

Biocompatibility of a biodegradable, controlled-release polymer in the rabbit brain.

1 reference

12 December 2020

Studies on the antitumor activity, mechanism of action, and cell cycle effects of camptothecin

1 reference

12 December 2020

Treatment of malignant melanoma with camptothecin (NSC-100880)

1 reference

12 December 2020

Mechanistic aspects of DNA topoisomerases.

1 reference

12 December 2020

Camptothecins: from bench research to hospital wards.

1 reference

12 December 2020

Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer.

1 reference

12 December 2020

Intracellular degradation of HeLa and adenovirus type 2 DNA induced by camptothecin

1 reference

12 December 2020

Resistance of human leukemic and normal lymphocytes to drug-induced DNA cleavage and low levels of DNA topoisomerase II

1 reference

12 December 2020

Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas

1 reference

12 December 2020

Phase I clinical trial of weekly and daily treatment with camptothecin (NSC-100880): correlation with preclinical studies.

1 reference

12 December 2020

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group

1 reference

12 December 2020

Brain biocompatibility of a biodegradable, controlled-release polymer in rats

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1015003232713

1 reference

Dimensions Publication ID

29 November 2017

0 references

1 reference